 |
|
The Metabolic Syndrome
Prevalence and Associated Risk Factor Findings in the US Population From the Third National Health and Nutrition Examination Survey, 1988-1994
Yong-Woo Park, MD, PhD;
Shankuan Zhu, MD, PhD;
Latha Palaniappan, MD;
Stanley Heshka, PhD;
Mercedes R. Carnethon, PhD;
Steven B. Heymsfield, MD
Arch Intern Med. 2003;163:427-436.
ABSTRACT
| |
Background The metabolic syndrome is an important cluster of coronary heart disease risk factors with common insulin resistance. The extent to which the metabolic syndrome is associated with demographic and potentially modifiable lifestyle factors in the US population is unknown.
Methods Metabolic syndrome–associated factors and prevalence, as defined by Adult Treatment Panel III criteria, were evaluated in a representative US sample of 3305 black, 3477 Mexican American, and 5581 white men and nonpregnant or lactating women aged 20 years and older who participated in the cross-sectional Third National Health and Nutrition Examination Survey.
Results The metabolic syndrome was present in 22.8% and 22.6% of US men and women, respectively (P = .86). The age-specific prevalence was highest in Mexican Americans and lowest in blacks of both sexes. Ethnic differences persisted even after adjusting for age, body mass index, and socioeconomic status. The metabolic syndrome was present in 4.6%, 22.4%, and 59.6% of normal-weight, overweight, and obese men, respectively, and a similar distribution was observed in women. Older age, postmenopausal status, Mexican American ethnicity, higher body mass index, current smoking, low household income, high carbohydrate intake, no alcohol consumption, and physical inactivity were associated with increased odds of the metabolic syndrome.
Conclusions The metabolic syndrome is present in more than 20% of the US adult population; varies substantially by ethnicity even after adjusting for body mass index, age, socioeconomic status, and other predictor variables; and is associated with several potentially modifiable lifestyle factors. Identification and clinical management of this high-risk group is an important aspect of coronary heart disease prevention.
INTRODUCTION
CORONARY HEART disease (CHD) is the leading cause of death in the United States.1 Factors associated with an increased risk of developing CHD that tend to cluster in individuals include older age, high blood pressure, a low level of high-density lipoprotein (HDL) cholesterol, a high triglyceride level, a high plasma glucose concentration, and obesity.2 These associated risk factors have been called syndrome X,3 the insulin resistance syndrome,4 or the metabolic syndrome.5
The mechanisms underlying the metabolic syndrome are not fully known; however, resistance to insulin-stimulated glucose uptake seems to modify biochemical responses in a way that predisposes to metabolic risk factors.3, 6-7 Insulin resistance is thought to be primarily due to obesity or an inherited genetic defect.8 As the prevalence of obesity increases in the United States, the prevalence of the metabolic syndrome may be expected to increase markedly. Estimates of the prevalence of the metabolic syndrome have varied substantially in part because of the variability of evaluated populations and of diagnostic criteria.9
The recent Third Report of the National Cholesterol Education Program Adult Treatment Panel (ATP III) included clinical diagnosis guidelines for the metabolic syndrome.10 Compared with findings from earlier studies3-5 and World Health Organization guidelines, the new ATP III defines criteria readily measured in clinical practice. These consensus-generated guidelines provide the opportunity to assess the overall prevalence of the metabolic syndrome in the US population according to an accepted standard definition. In an initial study, Ford et al11 reported unadjusted and age-adjusted metabolic syndrome prevalences of 21.8% and 23.7%, respectively, for the US population. The objectives of this study are to examine the prevalence of the metabolic syndrome by ethnicity, age, body mass index (BMI) (calculated as weight in kilograms divided by the square of height in meters), socioeconomic status, and lifestyle factors.
METHODS
STUDY POPULATION
The Third National Health and Nutrition Examination Survey (NHANES III) was conducted in two 3-year phases (October 18, 1988, to October 24, 1991, and September 20, 1991, to October 15, 1994) by the National Center for Health Statistics to assess the health and nutritional status of the noninstitutionalized US population. Conducted at 89 locations, the study used stratified, multistage probability cluster sampling, similar to that used in the 2 previous surveys. Weights indicating the probability of being sampled were assigned to each respondent, enabling results to represent the entire noninstitutionalized US population. The design of NHANES III is described in detail elsewhere.12
The NHANES III staff conducted surveys in households, administering questionnaires to families, adults, and children. Household surveys included demographic, socioeconomic, dietary, and health history questions. Standardized medical examinations were completed at mobile medical centers and included measurements related to metabolic syndrome criteria, including blood pressure, plasma lipid and glucose levels, and waist circumference. All survey instruments were available in English and Spanish.
The sample included non-Hispanic blacks (blacks), Mexican Americans, non-Hispanic whites (whites), and the "other" ethnicity category, aged 20 years or older at the time of NHANES III evaluation for whom anthropometric variables (ie, weight, height, and waist circumference), blood pressure, and blood studies (ie, glucose, total cholesterol, HDL cholesterol, and triglyceride levels) had been measured. Of 14 852 individuals, we excluded 1756 who consumed food or beverages other than water within 6 hours of venipuncture. In addition, we also excluded 235 women who were pregnant or lactating at baseline. Of the remaining 12 861 individuals, there were 3305 blacks (1494 men and 1811 women), 3477 Mexican Americans (1811 men and 1666 women), 5581 whites (2626 men and 2955 women), and 498 classified as other ethnicities (214 men and 284 women). A total of 5964 individuals aged 20 years or older in NHANES III were not included because of missing anthropometric measurements or blood studies or because they were not fasting. These 5964 individuals had a mean age similar to that of the 12 861 individuals who had the required anthropometric measurements and blood studies available and who had not consumed food or beverages for at least 6 hours before venipuncture (men: 43.9 vs 43.0 years; P = .12; women: 46.2 vs 46.3 years; P = .80).
METABOLIC SYNDROME CRITERIA
The ATP III clinical definition of the metabolic syndrome10 requires the presence of 3 or more of the following: (1) abdominal obesity (waist circumference >102 cm in men and >88 cm in women); (2) a high triglyceride level ( 150 mg/dL [1.69 mmol/L]); (3) a low HDL cholesterol level (<40 mg/dL [<1.03 mmol/L] for men and <50 mg/dL [<1.29 mmol/L] for women); (4) high blood pressure (systolic 130 mm Hg or diastolic 85 mm Hg); and (5) a high fasting plasma glucose concentration (110 mg/dL). Individuals met the criteria for high blood pressure or high fasting glucose concentration if they were currently using blood pressure medications or oral hypoglycemic diabetes mellitus control. Individuals with a previous physician diagnosis of hypertension or diabetes mellitus who did not report medication use were not allocated to the metabolic syndrome group.
VARIABLE DEFINITION
Normal weight, overweight, and obesity were defined as a BMI less than 25, 25 to 29.9, and 30 or higher, respectively. Education level was divided into 4 categories: less than 8 years, 8 to 12 years, greater than 12 years, and unknown. Economic status was divided into 4 categories according to the participant's household income for the previous year: $15 000 or less, $15 001 to $25 000, greater than $25 000, and unknown. Smoking was categorized as current, past, and never. Past smokers were those who reported that they had smoked at least 100 cigarettes during their lifetime but who did not currently smoke cigarettes. Drinking was categorized as heavy, moderate, never, and unknown. Heavy drinkers were defined as those who ever drank 5 or more alcoholic beverages per day or who drank beer, wine, or hard liquor 1 time per day during the past month. Moderate drinkers had an alcoholic beverage (ie, beer, wine, or hard liquor) less than once per day during the past month. Never drinkers were those who did not drink beer, wine, or hard liquor during the past month. Physical activity level was defined based on the participant's physical activity density rating scores obtained from participating in one of the following activities during the past month: walking, jogging or running, bicycle riding, swimming, lifting weights, or doing aerobics or aerobic dancing, other dancing, calisthenics, or garden or yard work. Participants in the physically inactive category included those with a total density rating score of 3.5 or less. The point at which the total density rating score equals 3.5 corresponds to approximately the 15th and 25th percentile in the male and female study populations, respectively. Earlier studies13-14 hypothesize a link between dietary composition and metabolic syndrome risk, particularly carbohydrate as an energy source. We selected carbohydrate intake, expressed as a percentage of total kilocalories, as one relevant measure of dietary composition. The percentage of total caloric intake from carbohydrates was evaluated by categorizing intake as high (>60%), middle (40%-60%), and low (<40%). Menopausal status was defined according to self-reported cessation of menstruation at interview.
STATISTICAL METHODS
Sex- and ethnic-specific prevalence rates of the metabolic syndrome were calculated for black, Mexican American, and white participants. Other ethnic groups were included when calculating the prevalence of the metabolic syndrome in the total US adult population. The metabolic syndrome age- and BMI-specific prevalence rates and 95% confidence intervals were also computed. Graphical presentation of prevalence rates for the metabolic syndrome are provided in 10-year increments. The term overall abnormalities is defined as the frequency in participants of a metabolic syndrome risk factor regardless of whether they also had other risk factors. The term isolated abnormalities is defined as the frequency in participants of only 1 risk factor for the metabolic syndrome. The frequencies of overall and isolated components of the metabolic syndrome were calculated for participants in 3 categorical age groups: young (20-34 years), middle aged (35-64 years), and old (65 years).
The adjusted Wald  2 test was used to evaluate the statistical significance of the prevalence rates of the metabolic syndrome and the frequencies of overall abnormalities among blacks, Mexican Americans, and whites, with Bonferroni adjustment for multiple comparisons.
Multiple logistic regression analysis was used for men and women to estimate the odds ratios (ORs) of the metabolic syndrome by age, ethnicity, BMI, smoking and drinking habits, carbohydrate intake, physical activity status, education and household income levels, and menopausal status. The regression model was used to test the interaction between BMI and sex as an independent variable and with the presence of the metabolic syndrome as a dependent variable.
All analyses incorporated sampling weights to produce nationally representative estimates. We used statistical software (Stata, version 7.0 for Windows; Stata Corp, College Station, Tex) to calculate weighted means, percentages, ORs, and SEs to adjust for the complex NHANES III sampling design. Statistical significance was set at P<.05 unless otherwise indicated.
RESULTS
OVERALL PREVALENCE
The anthropometric and sociodemographic characteristics of the participants are summarized in Table 1 and Table 2. The overall percentage of the metabolic syndrome in US adults, including blacks, Mexican Americans, whites, and others, was 22.8% for men and 22.6% for women as defined by the ATP III guidelines (P = .86).
|
|
|
|
Table 1. Anthropometric Characteristics of the Study Sample*
|
|
|
|
|
|
|
Table 2. Sociodemographic Characteristics of the Study Sample*
|
|
|
ETHNIC-SPECIFIC PREVALENCE
The percentage of participants with the metabolic syndrome was 13.9%, 20.8%, and 24.3%, for black, Mexican American, and white men, respectively. The percentage of men with the metabolic syndrome was higher in Mexican American and white men than in black men (P<.001 and P = .006, respectively; statistical significance set at P<.017); the difference between Mexican American and white men was not statistically significant (P = .06; statistical significance set at P<.017).
The percentage of black and white women with the metabolic syndrome was 20.9% and 22.9%, respectively, and there was no significant between–ethnic group difference (P = .10; statistical significance set at P<.017). The percentage of Mexican American women with the metabolic syndrome was significantly higher, 27.2%, than that of black and white women (P<.001 and P = .002, respectively; statistical significance set at P<.017).
AGE-SPECIFIC PREVALENCE
The prevalence of the metabolic syndrome by 10-year age groups is presented in Figure 1. Mexican American men showed the highest prevalence of the metabolic syndrome, followed by white men and then black men. Compared with that for black men, the prevalence of the metabolic syndrome for Mexican American men was significantly higher at 40, 50, 60, and 80 years or older, whereas white men showed a significantly higher prevalence at 40, 50, 70, and 80 years or older (P<.017). There were no statistically significant differences in the prevalence of the metabolic syndrome between Mexican American and white men at any age group.
|
|
|
|
Figure 1. The prevalence of the metabolic syndrome by age in men (A) and women (B). Statistical significance is set at P<.017. Error bars represent the 95% confidence interval, expressed as the mean ± 1.96 SE.
|
|
|
The prevalence of the metabolic syndrome for Mexican American women was highest among the 3 ethnic groups, followed by black women and then white women. Mexican American women showed a significantly higher prevalence for the 10-year age increments between 30 and 60 years compared with white women and at age 30 years compared with black women (P<.017) (Figure 1). There were no statistically significant differences in the prevalence of the metabolic syndrome between black and white women at any age group.
In both sexes, the prevalence of the metabolic syndrome increased steeply after the third decade and reached a peak in men aged 50 to 70 years and in women aged 60 to 80 years.
BMI-SPECIFIC PREVALENCE
The association between the prevalence of the metabolic syndrome and BMI, in increments of 2, is presented in Figure 2. A steep rise in the prevalence of the metabolic syndrome is observed in overweight (ie, BMI 25 and <30) men and women.
|
|
|
|
Figure 2. The prevalence of the metabolic syndrome by body mass index (calculated as weight in kilograms divided by the square of height in meters) in men (A) and women (B).
|
|
|
Overall, 4.6%, 22.4%, and 59.6% of normal-weight, overweight, and obese men, respectively, met the metabolic syndrome diagnostic criteria. Similarly, in women, the corresponding prevalence rates were 6.2%, 28.1%, and 50.0%, respectively.
COMPONENTS OF THE METABOLIC SYNDROME
The overall relative frequency of each component of the metabolic syndrome is given in Table 3 for men and in Table 4 for women. Although the frequencies of abnormal components were highly variable, several patterns are evident. Black men had a significantly higher frequency of high blood pressure (35- to 64-year age group) but lower frequencies of large waist (35- to 64-year age group) and high triglyceride and low HDL cholesterol levels (35- to 64- and 65-year age groups) compared with the other 2 ethnic groups. Mexican American women had a significantly higher frequency of elevated triglyceride levels in the young and middle age groups and a low HDL cholesterol level in the young age group compared with the other ethnic groups. Black women had a significantly higher frequency of high blood pressure, whereas white women had a significantly lower frequency of large waist circumference in the young and middle age groups compared with other ethnic groups.
|
|
|
|
Table 3. Prevalence of Each Metabolic Syndrome Component in Men*
|
|
|
|
|
|
|
Table 4. Prevalence of Each Metabolic Syndrome Component in Women*
|
|
|
The percentage of participants with each component of the metabolic syndrome who presented with the abnormality in isolated form is summarized in Table 3 for men and in Table 4 for women. In the 35- to 64-year age group, isolated high blood pressure was relatively frequent in black men (19.7%) compared with other isolated components (<10.0%). The proportion of individuals with a large waist was relatively high in the comparably aged women relative to other isolated components.
MULTIPLE LOGISTIC REGRESSION MODELS
Two multiple logistic regression models with the same covariates, except for age, are given in Table 5. Age in model 1 was divided into 3 categories: young, middle aged, and old. Age in model 2 was considered as a continuous variable. After adjusting for age in model 2, BMI, lifestyle-related factors, and socioeconomic status, blacks still showed a significantly lower OR for the metabolic syndrome compared with white men and women. Mexican Americans showed a significantly higher OR only in women. Significantly higher ORs were present in the 35- to 64-year and 65 years and older age groups compared with the 20- to 34-year age group in men and women as derived from model 1 with the same covariates. The ORs were 2.8 and 2.4 in the 35- to 64-year age group and 5.8 and 4.9 in those 65 years and older in men and women, respectively.
|
|
|
|
Table 5. Multivariable Adjusted ORs for the Metabolic Syndrome
|
|
|
The ORs for the metabolic syndrome in the overweight group relative to the normal-weight group were 5.2 for men and 5.4 for women. The ORs sharply increased to 25.2 and 67.7 for men and 14.0 and 34.5 for women when BMI was 30 to 34.9 and 35 or greater, respectively. When both sexes are modeled together using multiple logistic regression, the ORs for the interaction of BMI and sex were significant at BMI 30 to 34.9 (P<.001) and 35 or greater (P<.01).
Currently smoking men and women were at significantly higher risk of having the metabolic syndrome. In men, the ORs were significantly higher in the high carbohydrate intake and physical inactivity groups. In women, significantly higher ORs were observed in previous smokers, nondrinkers, and those with a low household income or who were postmenopausal. Women who were heavy alcohol consumers showed a significantly lower OR than women in the slight or moderate alcohol-consuming group.
COMMENT
Coronary heart disease remains the leading cause of mortality in the United States, accounting for more than 460 000 deaths in 2000.1 The primary target of CHD prevention, according to ATP III guidelines,10 is identification and appropriate treatment of patients with elevated LDL cholesterol levels. A secondary target, the metabolic syndrome, has been recognized for several decades3 but only recently was provided with consensus-generated diagnostic criteria by the ATP III.10 These criteria provided us with a framework for evaluating the main features of the metabolic syndrome in the US adult noninstitutionalized civilian population. Our findings, supporting and extending the initial findings of Ford et al,11 suggest that the metabolic syndrome is widespread among US adults; that prevalence rates are highly variable among ethnic, age, and BMI groups; and that lifestyle factors such as smoking, physical inactivity, and percentage of dietary caloric intake as carbohydrate are linked with the presence of the metabolic syndrome. These observations provide a foundation for CHD prevention initiatives and also raise important questions surrounding the applicability of the metabolic syndrome diagnostic criteria.
PREVALENCE OF THE METABOLIC SYNDROME
The present study results, based on NHANES III, indicate that approximately one fourth of US adults 20 years or older meet the diagnostic criteria for the metabolic syndrome. Prevalence rates were similar in men and women, with relative risk elevated in postmenopausal vs premenopausal women. Our results extend those of earlier studies,7, 15-21 based on variable criteria, reporting metabolic syndrome prevalence rates ranging from 2.4% to 35.3%.
Ethnicity
Our findings suggest that metabolic syndrome prevalence rates vary among ethnic groups, ranging from a low of 13.9% in black men to a high of 27.2% in Mexican American women. These ethnic differences persisted even after adjusting for contributing factors such as age, BMI, smoking and drinking habits, socioeconomic status, physical inactivity, and menopausal status among women. Our findings are consistent with those of earlier studies indicating that compared with whites, Mexican Americans are more prone to develop hyperinsulinemia, insulin resistance, and an unfavorable distribution of body fat, which are the central features of the metabolic syndrome.22-23
Blacks are more insulin resistant than whites at a similar degree of adiposity.22-25 Blacks also have the highest overall CHD mortality rate of any ethnic group,26 and black men have a 60% higher incidence of type 2 diabetes mellitus than white men.27 On the other hand, the prevalence of the metabolic syndrome as defined by ATP III criteria in this study was lowest in black men. This lower prevalence in black men was accompanied by significantly lower frequencies of large waist, high triglyceride levels, and low HDL cholesterol levels, but black men had a greater frequency of high blood pressure. Other factors, such as smoking, small LDL particle size, prothrombotic state, family history, and environmental risk factors, may occur more frequently in blacks. Brancati et al28 reported that US blacks had a lower education level, were more likely to have a family history of diabetes mellitus, and engaged in less physical activity during leisure time than whites. Other factors related to ethnicity and socioeconomic status may also affect mortality risk, separate from those leading to the metabolic syndrome, such as access to early diagnosis and treatment.
An important question arising from these observations is the validity of the metabolic syndrome criteria when applied across different age, sex, and ethnic groups. Each of the metabolic syndrome criteria are now weighted equally, although some may be more potent CHD risk factors than others. Thus, the power of single components of the metabolic syndrome to predict eventual disease may differ across ethnic groups. The metabolic syndrome "cutoff points" may also vary by ethnic group. For example, for the same waist circumference, blacks have relatively smaller depots of insulin resistance related to visceral adipose tissue compared with whites.29 Insulin resistance is also associated with blood pressure levels in white but not black Americans.30 Future longitudinal studies are needed to critically test ATP III criteria for the metabolic syndrome, particularly as they apply to the predictive validity for the development of disease across different ethnic groups.
Age
The prevalence of the metabolic syndrome rose with age, reaching peak levels in the sixth decade for men and the seventh decade for women. Prevalence rates declined in the eighth decade for men and women in some ethnic groups. The marked prevalence increase between the third and fifth decades is paralleled by similar increases among US civilians in the prevalence of overweight and obesity,8 key related factors in the development of visceral adiposity, insulin resistance, dyslipidemias, high blood pressure, and impaired glucose metabolism. In addition, aging per se is associated with evolution of insulin resistance, other hormonal alterations, and increases in visceral adipose tissue,31 all of which are important in the pathogenesis of the metabolic syndrome.
Body Mass Index
Although less than 6% of normal-weight adults met the criteria for the metabolic syndrome, rates increased in overweight participants and reached a prevalence of approximately 60% in moderately obese participants with a BMI of approximately 35. The ORs for the metabolic syndrome increased, beginning in the overweight group, as a function of BMI. The OR increase in men exceeded that in women with a BMI greater than 30, indicating that men may be more sensitive to excessive weight gain than women. Participants with BMI less than 25 meeting the metabolic syndrome criteria may be the "metabolically obese, normal-weight" individuals referred to by Ruderman et al32 who purportedly have insulin resistance as the central feature of their cluster of metabolic abnormalities.
Although BMI serves as a useful marker of obesity and related insulin resistance, stronger correlations are observed between abdominal obesity and metabolic risk factors.20, 32-35 The ATP III included waist circumference as a proxy measure of abdominal obesity, and waist circumference is well correlated with visceral adipose tissue36-38 and is a better anthropometric predictor of metabolic risk factors than BMI.35, 39-40 Easily measured waist circumference is thus a simple and useful tool for identifying patients who are susceptible to the metabolic syndrome.22
SOCIOECONOMIC AND LIFESTYLE CHARACTERISTICS
Many studies41-43 have reported that low socioeconomic status is associated with a higher mortality rate for cardiovascular disease. A low education level links cardiovascular disease with risk factors such as smoking,41, 44-46 hypertension,41, 45 impaired glucose tolerance,47 diabetes mellitus,48 physical inactivity,45-46,49 and overweight with associated metabolic disturbances.41, 45-47 No significant associations were observed in the present study between education level and the odds of having the metabolic syndrome. In women, however, the OR for the metabolic syndrome was significantly increased in the low household income group. In addition, a variety of lifestyle associations increased the odds of meeting the metabolic syndrome diagnostic criteria. Significantly higher ORs were found in currently smoking men and women than in their nonsmoking counterparts. The association between smoking and the metabolic syndrome remained even after adjusting for other covariates, possibly a reflection of the effect of cigarette smoking on insulin resistance.50 The association of low education levels with elevated risk is likely mediated by other risk factors, such as low household income, smoking, high carbohydrate intake, and physical inactivity.
The prevalence of the metabolic syndrome was elevated in women who abstained from alcohol. Slight and moderate alcohol consumption has been found in epidemiologic studies to be associated with low CHD risk, possibly through beneficial alterations in HDL cholesterol and blood pressure.51-53 There was an additional lowering of the odds of having the metabolic syndrome with high alcohol intake in women. In men, the odds of having the metabolic syndrome were increased in those who ingested a relatively large proportion of their calories from carbohydrates. High carbohydrate intake may predispose individuals to elevated triglyceride and low HDL cholesterol levels, 2 components of the metabolic syndrome.54
The OR was significantly increased for physical inactivity in men. Physical inactivity also imparts an increased risk for CHD and type 2 diabetes mellitus and exacerbates the severity of other risk factors.55 Increased physical activity promotes weight loss and maintenance in obese individuals56 and favorably modifies obesity-associated risk factors, including promoting visceral adipose tissue loss, improving insulin sensitivity, increasing HDL cholesterol levels, and lowering triglyceride levels.45-46,49
STUDY LIMITATIONS
The principal limitation relevant to the interpretation of our results is the use of cross-sectional data; thus, causal pathways underlying the observed relationships cannot be inferred. In addition, our investigation included only one dietary marker outside of alcohol intake: percentage of calories from carbohydrates. Future studies should consider additional dietary variables that are known to affect lipid levels and to be associated with educational status.44, 57-58 Finally, the NHANES III database was developed between 1988 and 1994, and the observed prevalence rates may differ from those actually present in the current US population. The NHANES IV database will be available in the near future, allowing for adjustment of the prevalence rates reported in this trial.
CLINICAL IMPLICATIONS
An important advance embodied in the new ATP III criteria for the metabolic syndrome is that all 5 components can be easily evaluated in the clinical setting. Our findings and those of Ford et al11 indicate that more than 1 in 5 patients, and more in some populations, will meet these criteria and harbor what is usually a clinically silent aggregate of CHD risk factors. Although for many obese patients risk is already evident, our findings reveal that the risk of having the metabolic syndrome increases steeply even within the overweight or "preobese" range, with approximately 20% of individuals affected between a BMI of 25 and 29.9. Detecting these overweight individuals and the 6% of normal-weight individuals with the metabolic syndrome and implementing preventive lifestyle interventions—diet education, physical activity, weight control, smoking cessation, and related behavior modification—is a high clinical priority. Support for this recommendation is provided by recent studies demonstrating a slowing in the rate of new type 2 diabetes mellitus onset with lifestyle interventions in individuals with impaired glucose tolerance.59-61
In conclusion, more than 20% of US adults have the metabolic syndrome as defined by ATP III. The present study not only reveals the exceptionally high prevalence of the metabolic syndrome within some specific groups but also brings forth important questions surrounding the mechanisms of between–ethnic group differences and on the validity of a unified set of diagnostic criteria. The increasing number of overweight and obese individuals of all ages combined with the growing number of elderly people promises to make the metabolic syndrome an increasingly common condition amenable to preventive lifestyle interventions.
AUTHOR INFORMATION
Corresponding author and reprints: Steven B. Heymsfield, MD, Obesity Research Center, 1090 Amsterdam Ave, New York, NY 10025 (e-mail: sbh2{at}columbia.edu).
Accepted for publication June 14, 2002.
This study was supported by grant DK42618 from the National Institutes of Health, Bethesda, Md, and a donation from Bristol Myers Corp, New York, NY.
From the Department of Family Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea (Dr Park); the Obesity Research Center, St Luke's–Roosevelt Hospital, Institute of Human Nutrition, College of Physicians and Surgeons, Columbia University, New York, NY (Drs Zhu, Heshka, and Heymsfield); and the Stanford Center for Research in Disease Prevention, Stanford University School of Medicine, Palo Alto, Calif (Drs Palaniappan and Carnethon).
REFERENCES
| |
1. American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 2000.
2. Wilson PWF, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159:1104-1109.
FREE FULL TEXT
3. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
ABSTRACT
4. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin resistance syndrome (syndrome X). Diabetes. 1992;41:715-722.
ABSTRACT
5. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol. 1999;83:25F-29F.
6. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
ABSTRACT
7. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416-422.
FULL TEXT
|
ISI
| PUBMED
8. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998;20:157-172.
FREE FULL TEXT
9. Abate N. Obesity and cardiovascular disease: pathogenic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications. 2000;14:154-174.
FULL TEXT
|
ISI
| PUBMED
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2496.
FREE FULL TEXT
11. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359.
FREE FULL TEXT
12. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Vital Health Stat 1. 1994;32:1-407.
13. Willett WC. Will high-carbohydrate/low-fat diets reduce the risk of coronary heart disease? Proc Soc Exp Biol Med. 2000;225:187-190.
FREE FULL TEXT
14. Wirfält E, Hedblad B, Gullberg B, et al. Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the Malmö Diet and Cancer Cohort. Am J Epidemiol. 2001;154:1150-1159.
FREE FULL TEXT
15. Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes. 1998;47:1643-1649.
ABSTRACT
16. Greenlund KJ, Rith-Najarian S, Valdez R, Croft JB, Casper ML. Prevalence and correlates of the insulin resistance syndrome among native Americans: the Inter-tribal Heart Project. Diabetes Care. 1999;22:441-447.
ABSTRACT
17. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Nahida HG, Jervell J. The metabolic syndrome in the West Bank population. Diabetes Care. 2001;24:275-279.
FREE FULL TEXT
18. Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesaniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med. 1999;245:163-174.
FULL TEXT
|
ISI
| PUBMED
19. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G. A metabolic syndrome in whites and African Americans. Diabetes Care. 1996;19:414-418.
ABSTRACT
20. Vanhala MJ, Pitkajarvi TK, Kumpusalo EA, Takala JK. Obesity type and clustering of insulin resistance–associated cardiovascular risk factors in middle-aged men and women. Int J Obes. 1998;22:369-374.
FULL TEXT
|
ISI
21. Wilson PWF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
FREE FULL TEXT
22. Okosun IS, Liao Y, Rotimi CN, Prewitt TE, Cooper RS. Abdominal adiposity and clustering of multiple metabolic syndrome in White, Black and Hispanic Americans. Ann Epidemiol. 2000;10:263-270.
FULL TEXT
|
ISI
| PUBMED
23. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK, Malina RM. Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. Int J Obes. 1986;10:493-502.
ISI
| PUBMED
24. Haffner SM, D'Agostino R Jr, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes. 1996;45:742-748.
ABSTRACT
25. Karter AJ, Mayer-Davis EJ, Selby JV, et al. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women: the Insulin Resistance and Atherosclerosis Study. Diabetes. 1996;45:1547-1555.
ABSTRACT
26. Gillum RF. Cardiovascular disease in the United States: an epidemiologic overview. In: Saunders E, ed. Cardiovascular Disease in Blacks. Philadelphia, Pa: FA Davis Co Publishers; 1991:3-16.
27. Harris MI. Noninsulin-dependent diabetes mellitus in black and white Americans. Diabetes Metab Rev. 1990;6:71-90.
ISI
| PUBMED
28. Brancati FL, Linda Kao WH, Folsom AR, Watson RL, Szklo M. Incident type 2 diabetes mellitus in African American and white adults. JAMA. 2000;283:2253-2259.
FREE FULL TEXT
29. Conway JM, Yanovski SZ, Avila NA, Hubbard VS. Visceral adipose tissue differences in black and white women. Am J Clin Nutr. 1995;61:765-771.
FREE FULL TEXT
30. Saad MF, Lillioja S, Nyomba BL, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991;324:733-739.
ABSTRACT
31. Boden G, Chen X, DeSantis RA, Kendrick Z. Effects of age and body fat on insulin resistance in healthy men. Diabetes Care. 1993;16:728-733.
ABSTRACT
32. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998;47:699-713.
ABSTRACT
33. Vanhala MJ, Kumpusalo EA, Pitkajarvi TK, Takala JK. Metabolic syndrome in a middle-aged Finnish population. J Cardiovasc Risk. 1997;4:291-295.
FULL TEXT
| PUBMED
34. Vanhala MJ, Kumpusalo EA, Pitkajarvi TK, Notkola IL, Takala JK. Hyperinsulinemia and clustering of cardiovascular risk factors in middle-aged hypertensive Finnish men and women. J Hypertens. 1997;15:475-481.
FULL TEXT
|
ISI
| PUBMED
35. Haffner SM, Ferrannini E, Hazuda HP, Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension. 1992;20:38-45.
FREE FULL TEXT
36. Han TS, Leer EM, Seidell JC, Lean MEJ. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ. 1995;311:1401-1405.
FREE FULL TEXT
37. Pouliot MC, Despres JP, Lemieux S, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460-468.
FULL TEXT
|
ISI
| PUBMED
38. Ross R, Léger L, Morris D, de Guise J, Guardo R. Quantification of adipose tissue by MRI: relationship with anthropometric variables. J Appl Physiol. 1992;72:787-795.
FREE FULL TEXT
39. Wei M, Caskill SP, Haffner SM, Stern MP. Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio over other anthropometric measurements in Mexican Americans: a 7-year prospective study. Obes Res. 1997;5:16-23.
ISI
| PUBMED
40. Siedell JC, Oosterlee A, Deurenberg P, Hautvast JGMJ, Ruys JHJ. Abnormal fat depots measured with computed tomograph: effect of obesity, sex and age. Eur J Clin Nutr. 1988;42:805-807.
ISI
| PUBMED
41. Pekkanen J, Tuomilehto J, Uutela A, Vartiainen E, Nissinen A. Social class, health behaviors, and mortality among men and women in eastern Finland. BMJ. 1995;311:589-593.
FREE FULL TEXT
42. Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J. Mortality differences between black and white men in the USA: contribution of income and other risk factors among men screened for the MRFIT. Lancet. 1998;351:934-939.
ISI
| PUBMED
43. Kaplan GA, Keil JE. Socieconomic factors and cardiovascular disease: a review of the literature. Circulation. 1993;88:1973-1998.
FREE FULL TEXT
44. Jacobsen BK, Thelle DS. Risk factors for coronary heart disease and level of education: the Tromso Heart Study. Am J Epidemiol. 1988;127:923-932.
FREE FULL TEXT
45. Hoeymans N, Smit HA, Verkleij H, Kromhout D. Cardiovascular risk factors in relation to educational level in 36,000 men and women in the Netherlands. Eur Heart J. 1996;17:518-524.
FREE FULL TEXT
46. Choinniere R, Lafontaine P, Edwards AC. Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. CMAJ. 2000;162(suppl):S13-S24.
47. Brunner EJ, Marmot MG, Nanchahal K, et al. Social inequality in coronary risk: central obesity and the metabolic syndrome: evidence from the Whitehall II Study. Diabetologia. 1997;40:1341-1349.
FULL TEXT
|
ISI
| PUBMED
48. Brancati FL, Whelton PK, Kuller LH, Klag MJ. Diabetes mellitus, race, and socioeconomic status: a population-based study. Ann Epidemiol. 1996;6:67-73.
FULL TEXT
|
ISI
| PUBMED
49. Rosengren A, Wilhelmsen L. Physical activity protects against coronary death and deaths from all causes in middle-aged men. Ann Epidemiol. 1997;7:69-75.
FULL TEXT
|
ISI
| PUBMED
50. Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance: a potential link with the insulin resistance syndrome. J Intern Med. 1993;233:327-332.
ISI
| PUBMED
51. Jackson R, Stewart A, Beaglehole R, Scragg R. Alcohol consumption and blood pressure. Am J Epidemiol. 1985;122:1037-1044.
FREE FULL TEXT
52. Gillman MW, Cook NR, Evans DA, et al. Relationship of alcohol intake with blood pressure in young adults. Hypertension. 1995;25:1106-1110.
FREE FULL TEXT
53. Gaziano JM, Buring JE, Breslow JL, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subtractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329:1829-1831.
FREE FULL TEXT
54. Liu S, Manson JE, Stampfer MJ, et al. Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr. 2001;73:560-566.
FREE FULL TEXT
55. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion. Surgeon General's Report on Physical Activity and Health. Atlanta, Ga: Centers for Disease Control and Prevention; 1996.
56. National Institutes of Health. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Bethesda, Md: National Institutes of Health; 2000. NIH publication 00-4084.
57. Shimakawa T, Sorlie P, Carpenter MA, et al. Dietary intake patterns and sociodemographic factors in the Atherosclerosis Risk in Communities Study. Prev Med. 1994;23:769-780.
FULL TEXT
|
ISI
| PUBMED
58. Bolton-Smith C, Smith WC, Woodward M, Tunstall-Pedoe H. Nutrient intake of different social-class groups: results from the Scottish Heart Health Study. Br J Nutr. 1991;65:321-335.
FULL TEXT
|
ISI
| PUBMED
59. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
FREE FULL TEXT
60. Pan X-R, Cao H-B, Li G-W, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. Diabetes Care. 1997;20:537-544.
ABSTRACT
61. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med. 2001;345:790-797.
FREE FULL TEXT
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
The Metabolic Syndrome: All Criteria Are Equal, but Some Criteria Are More Equal Than Others
Edoardo Giannini and Roberto Testa
Arch Intern Med. 2003;163(22):2787-2788.
EXTRACT
| FULL TEXT
The Metabolic Syndrome: All Criteria Are Equal, but Some Criteria Are More Equal Than Others—Reply
Yong-Woo Park, Shankuan Zhu, Steven B. Heymsfield, and Stanley Heshka
Arch Intern Med. 2003;163(22):2788.
EXTRACT
| FULL TEXT
RELATED ARTICLE
What to Do About the Metabolic Syndrome?
James O. Hill and Daniel Bessesen
Arch Intern Med. 2003;163(4):395-397.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
High Prevalence of Metabolic Syndrome in First-Degree Male Relatives of Women with Polycystic Ovary Syndrome Is Related to High Rates of Obesity
Coviello et al.
J. Clin. Endocrinol. Metab. 2009;94:4361-4366.
ABSTRACT
| FULL TEXT
Obesity in Elderly Subjects: In sheep's clothing perhaps, but still a wolf!
Osher and Stern
Diabetes Care 2009;32:S398-S402.
FULL TEXT
Transcutaneous Electrical Stimulation of Acupoints Changes Body Composition and Heart Rate Variability in Postmenopausal Women with Obesity
Chien et al.
Evid Based Complement Alternat Med 2009;0:nep145v2-nep145.
ABSTRACT
| FULL TEXT
Consequences of High Incarceration Rate and High Obesity Prevalence on the Prison System
Leddy et al.
J Correct Health Care 2009;15:318-327.
ABSTRACT
Low prevalence of the metabolic syndrome but high occurrence of various metabolic disorders in Chinese women with polycystic ovary syndrome
Ni et al.
Eur J Endocrinol 2009;161:411-418.
ABSTRACT
| FULL TEXT
Relationship between leisure-time physical activity and metabolic syndrome using varying definitions: 1999-2004 NHANES
Churilla and Fitzhugh
Diabetes and Vascular Disease Research 2009;6:100-109.
ABSTRACT
Progression of the Prevalence of Metabolic Syndrome in Normal-Weight US Subjects
Scheen
Arch Intern Med 2009;169:636-637.
FULL TEXT
Metabolic syndrome is an independent risk factor for stroke and acute renal failure after coronary artery bypass grafting.
Kajimoto et al.
J. Thorac. Cardiovasc. Surg. 2009;137:658-663.
ABSTRACT
| FULL TEXT
Progress and Challenges in Metabolic Syndrome in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism
Steinberger et al.
Circulation 2009;119:628-647.
FULL TEXT
Steroidogenic Capacity of Residual Ovarian Tissue in 4-Vinylcyclohexene Diepoxide-Treated Mice
Rivera et al.
Biol. Reprod. 2009;80:328-336.
ABSTRACT
| FULL TEXT
The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction
Traish et al.
J Androl 2009;30:10-22.
ABSTRACT
| FULL TEXT
CHAPTER 14 Diabetes Mellitus and Metabolic Syndrome
Cosentino et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT
| FULL TEXT
The Metabolic Syndrome
Cornier et al.
Endocr. Rev. 2008;29:777-822.
ABSTRACT
| FULL TEXT
Abnormal Cardiac Structure and Function in the Metabolic Syndrome: A Population-Based Study
Aijaz et al.
Mayo Clin Proc. 2008;83:1350-1357.
ABSTRACT
| FULL TEXT
Individual and Area-Based Indicators of Acculturation and the Metabolic Syndrome Among Low-Income Mexican American Women Living in a Border Region
Espinosa de los Monteros et al.
AJPH 2008;98:1979-1986.
ABSTRACT
| FULL TEXT
Individual and Neighborhood Socioeconomic Status Characteristics and Prevalence of Metabolic Syndrome: The Atherosclerosis Risk in Communities (ARIC) Study
Chichlowska et al.
Psychosom. Med. 2008;70:986-992.
ABSTRACT
| FULL TEXT
Metabolic Syndrome Affects Cardiovascular Risk Profile and Response to Treatment in Hypertensive Postmenopausal Women
Rossi et al.
Hypertension 2008;52:865-872.
ABSTRACT
| FULL TEXT
Prioritization of candidate disease genes for metabolic syndrome by computational analysis of its defining phenotypes
Tiffin et al.
Physiol. Genomics 2008;35:55-64.
ABSTRACT
| FULL TEXT
Physical activity, cardiorespiratory fitness, and the metabolic syndrome in youth
Steele et al.
J. Appl. Physiol. 2008;105:342-351.
ABSTRACT
| FULL TEXT
The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events study
Brevetti et al.
QJM 2008;101:575-582.
ABSTRACT
| FULL TEXT
Lifestyle and the Risk of Cardiovascular Disease in Women: Is Physical Activity an Equal Opportunity Benefactor?
Zoeller
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:219-226.
ABSTRACT
The Proinflammatory Mediator CD40 Ligand Is Increased in the Metabolic Syndrome and Modulated by Adiponectin
Natal et al.
J. Clin. Endocrinol. Metab. 2008;93:2319-2327.
ABSTRACT
| FULL TEXT
The Prevalence of Metabolic Syndrome Among US Women of Childbearing Age
Ramos and Olden
AJPH 2008;98:1122-1127.
ABSTRACT
| FULL TEXT
Distinct Component Profiles and High Risk Among African Americans With Metabolic Syndrome: The Jackson Heart Study
Taylor et al.
Diabetes Care 2008;31:1248-1253.
ABSTRACT
| FULL TEXT
Metabolic Phenotype in the Brothers of Women with Polycystic Ovary Syndrome
Sam et al.
Diabetes Care 2008;31:1237-1241.
ABSTRACT
| FULL TEXT
Glomerular Filtration Rate, Albuminuria, and Risk of Cardiovascular and All-Cause Mortality in the US Population
Astor et al.
Am J Epidemiol 2008;167:1226-1234.
ABSTRACT
| FULL TEXT
Prospective study of alcohol consumption and metabolic syndrome
Baik and Shin
Am. J. Clin. Nutr. 2008;87:1455-1463.
ABSTRACT
| FULL TEXT
Physical Activity: Physical Activity and the Metabolic Syndrome: A Review of the Evidence
Churilla and Zoeller
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2008;2:118-125.
ABSTRACT
Factors associated with metabolic syndrome in patients with systemic lupus erythematosus from Puerto Rico
Negron et al.
Lupus 2008;17:348-354.
ABSTRACT
Metabolic Syndrome Pandemic
Grundy
Arterioscler. Thromb. Vasc. Bio. 2008;28:629-636.
ABSTRACT
| FULL TEXT
A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor
Grundy
Eur Heart J Suppl 2008;10:B16-B23.
ABSTRACT
| FULL TEXT
Mas Deficiency in FVB/N Mice Produces Marked Changes in Lipid and Glycemic Metabolism
Santos et al.
Diabetes 2008;57:340-347.
ABSTRACT
| FULL TEXT
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Writing Group Members et al.
Circulation 2008;117:e25-e146.
FULL TEXT
Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people
Yamada et al.
J. Med. Genet. 2008;45:22-28.
ABSTRACT
| FULL TEXT
State of the Art Reviews: Relationship Between Diet/ Physical Activity and Health
O'Neil and Nicklas
AMERICAN JOURNAL OF LIFESTYLE MEDICINE 2007;1:457-481.
ABSTRACT
Severe Mental Illness and Risk of Cardiovascular Disease
Newcomer and Hennekens
JAMA 2007;298:1794-1796.
FULL TEXT
Clustering of Long-term Trends in Metabolic Syndrome Variables from Childhood to Adulthood in Blacks and Whites: The Bogalusa Heart Study
Chen et al.
Am J Epidemiol 2007;166:527-533.
ABSTRACT
| FULL TEXT
Association between Metabolic Syndrome and Sleep-disordered Breathing in Adolescents
Redline et al.
Am. J. Respir. Crit. Care Med. 2007;176:401-408.
ABSTRACT
| FULL TEXT
Milk and dairy consumption, diabetes and the metabolic syndrome: the Caerphilly prospective study
Elwood et al.
J. Epidemiol. Community Health 2007;61:695-698.
ABSTRACT
| FULL TEXT
Insulin Resistance: Link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth
Lee et al.
Diabetes Care 2007;30:2091-2097.
ABSTRACT
| FULL TEXT
Hispanic Paradox in Biological Risk Profiles
Crimmins et al.
AJPH 2007;97:1305-1310.
ABSTRACT
| FULL TEXT
Dissociation between metabolic and vascular insulin resistance in aging
Schulman et al.
Am. J. Physiol. Heart Circ. Physiol. 2007;293:H853-H859.
ABSTRACT
| FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J Suppl 2007;9:C3-C74.
FULL TEXT
The prevalence of syndrome Z (the interaction of obstructive sleep apnoea with the metabolic syndrome) in a teaching hospital in Singapore
Venkateswaran and Shankar
Postgrad. Med. J. 2007;83:329-331.
ABSTRACT
| FULL TEXT
Molecular Genetics of Experimental Hypertension and the Metabolic Syndrome: From Gene Pathways to New Therapies
Pravenec and Kurtz
Hypertension 2007;49:941-952.
ABSTRACT
| FULL TEXT
Differences in the prevalence of metabolic syndrome in urban and rural India: a problem of urbanization
Prabhakaran et al.
Chronic Illness 2007;3:8-19.
Metabolic syndrome, or What you will: definitions and epidemiology
Day
Diabetes and Vascular Disease Research 2007;4:32-38.
ABSTRACT
Television Viewing Is Associated With Prevalence of Metabolic Syndrome in Hispanic Elders
Gao et al.
Diabetes Care 2007;30:694-700.
ABSTRACT
| FULL TEXT
The Effect of Menopause on the Metabolic Syndrome Among Korean Women: The Korean National Health and Nutrition Examination Survey, 2001
Kim et al.
Diabetes Care 2007;30:701-706.
ABSTRACT
| FULL TEXT
The metabolic syndrome and the risk of thrombosis
Dentali et al.
haematol 2007;92:297-299.
FULL TEXT
Venous thromboembolism a manifestation of the metabolic syndrome
Ay et al.
haematol 2007;92:374-380.
ABSTRACT
| FULL TEXT
Consistently Stable or Decreased Body Mass Index in Young Adulthood and Longitudinal Changes in Metabolic Syndrome Components: The Coronary Artery Risk Development in Young Adults Study
Lloyd-Jones et al.
Circulation 2007;115:1004-1011.
ABSTRACT
| FULL TEXT
Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study
Scott Baker et al.
Blood 2007;109:1765-1772.
ABSTRACT
| FULL TEXT
Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2007;115:e69-e171.
FULL TEXT
Metabolic Syndrome: A Multiplex Cardiovascular Risk Factor
Grundy
J. Clin. Endocrinol. Metab. 2007;92:399-404.
ABSTRACT
| FULL TEXT
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Authors/Task Force Members et al.
Eur Heart J 2007;28:88-136.
FULL TEXT
Haplotypes in the Lipoprotein Lipase Gene Influence Fasting Insulin and Discovery of a New Risk Haplotype
Goodarzi et al.
J. Clin. Endocrinol. Metab. 2007;92:293-296.
ABSTRACT
| FULL TEXT
The Prevalence of the Metabolic Syndrome in Psychiatric Inpatients With Primary Psychotic and Mood Disorders
Bermudes et al.
Psychosomatics 2006;47:491-497.
ABSTRACT
| FULL TEXT
Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults
Villareal et al.
Am. J. Clin. Nutr. 2006;84:1317-1323.
ABSTRACT
| FULL TEXT
Social Circumstances and Education: Life Course Origins of Social Inequalities in Metabolic Risk in a Prospective National Birth Cohort
Langenberg et al.
AJPH 2006;96:2216-2221.
ABSTRACT
| FULL TEXT
Genetic relationship between placental and fetal weights and markers of the metabolic syndrome in rat recombinant inbred strains
Buresova et al.
Physiol. Genomics 2006;26:226-231.
ABSTRACT
| FULL TEXT
Coping, affect, and the metabolic syndrome in older men: how does coping get under the skin?
Yancura et al.
Journals of Gerontology Series B: Psychological Sciences and Social Science 2006;61:P295-P303.
ABSTRACT
| FULL TEXT
The Role of Diabetes and Components of the Metabolic Syndrome in Stroke and Coronary Heart Disease Mortality in U.K. White and African-Caribbean Populations.
Tillin et al.
Diabetes Care 2006;29:2127-2129.
FULL TEXT
RESPONSE: Re: Diabetes Mellitus and Risk of Colorectal Cancer in the Singapore Chinese Health Study
Seow et al.
JNCI J Natl Cancer Inst 2006;98:1019-1020.
FULL TEXT
Cardiovascular Death and the Metabolic Syndrome: Role of adiposity-signaling hormones and inflammatory markers.
Langenberg et al.
Diabetes Care 2006;29:1363-1369.
ABSTRACT
| FULL TEXT
Emergence of Cardiovascular Risk Factors From Mild Obesity in Japanese Elementary School Children.
Yoshinaga et al.
Diabetes Care 2006;29:1408-1410.
FULL TEXT
Relationship of Adolescent Polycystic Ovary Syndrome to Parental Metabolic Syndrome
Leibel et al.
J. Clin. Endocrinol. Metab. 2006;91:1275-1283.
ABSTRACT
| FULL TEXT
Renal Manifestations in the Metabolic Syndrome.
Locatelli et al.
J. Am. Soc. Nephrol. 2006;17:S81-S85.
ABSTRACT
| FULL TEXT
Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds
Grundy
J Am Coll Cardiol 2006;47:1093-1100.
ABSTRACT
| FULL TEXT
Stimulation of Urinary TGF-{beta} and Isoprostanes in Response to Hyperglycemia in Humans
McGowan et al.
CJASN 2006;1:263-268.
ABSTRACT
| FULL TEXT
Update in nephrology and hypertension.
Kimmel
ANN INTERN MED 2006;144:281-285.
FULL TEXT
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism
Poirier et al.
Circulation 2006;113:898-918.
ABSTRACT
| FULL TEXT
Heart Disease and Stroke Statistics--2006 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Thom et al.
Circulation 2006;113:e85-e151.
FULL TEXT
Women and Ischemic Heart Disease: Pathophysiologic Implications From the Women's Ischemia Syndrome Evaluation (WISE) Study and Future Research Steps
Quyyumi
J Am Coll Cardiol 2006;47:S66-S71.
ABSTRACT
| FULL TEXT
Cortisol correlates with metabolic disturbances in a population study of type 2 diabetic patients
Oltmanns et al.
Eur J Endocrinol 2006;154:325-331.
ABSTRACT
| FULL TEXT
Diabetes Mellitus and Risk of Colorectal Cancer in the Singapore Chinese Health Study
Seow et al.
JNCI J Natl Cancer Inst 2006;98:135-138.
ABSTRACT
| FULL TEXT
Metabolic syndrome in polycystic ovary syndrome (PCOS): lower prevalence in southern Italy than in the USA and the influence of criteria for the diagnosis of PCOS
Carmina et al.
Eur J Endocrinol 2006;154:141-145.
ABSTRACT
| FULL TEXT
Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial
Eberly et al.
Diabetes Care 2006;29:123-130.
ABSTRACT
| FULL TEXT
Educational disparities in the metabolic syndrome in a rapidly changing society--the case of South Korea
Kim et al.
Int J Epidemiol 2005;34:1266-1273.
ABSTRACT
| FULL TEXT
Metabolic syndrome
Khunti and Davies
BMJ 2005;331:1153-1154.
FULL TEXT
Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society
Villareal et al.
Am. J. Clin. Nutr. 2005;82:923-934.
ABSTRACT
| FULL TEXT
Population Comparison of Two Clinical Approaches to the Metabolic Syndrome: Implications of the new International Diabetes Federation consensus definition
Adams et al.
Diabetes Care 2005;28:2777-2779.
FULL TEXT
Estrogen Regulation of Adiposity and Fuel Partitioning: EVIDENCE OF GENOMIC AND NON-GENOMIC REGULATION OF LIPOGENIC AND OXIDATIVE PATHWAYS
D'Eon et al.
J. Biol. Chem. 2005;280:35983-35991.
ABSTRACT
| FULL TEXT
Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
Grundy et al.
Circulation 2005;112:2735-2752.
FULL TEXT
Chlorthalidone Improves Endothelial-Mediated Vascular Responses in Hypertension Complicated by Nondiabetic Metabolic Syndrome
Dell'Omo et al.
J CARDIOVASC PHARMACOL THER 2005;10:265-272.
ABSTRACT
Two Major QTLs and Several Others Relate to Factors of Metabolic Syndrome in the Family Blood Pressure Program
Kraja et al.
Hypertension 2005;46:751-757.
ABSTRACT
| FULL TEXT
Drinking Frequency, Mediating Biomarkers, and Risk of Myocardial Infarction in Women and Men
Mukamal et al.
Circulation 2005;112:1406-1413.
ABSTRACT
| FULL TEXT
An Exploratory Analysis of Criteria for the Metabolic Syndrome and Its Prediction of Long-term Cardiovascular Outcomes: The Hoorn Study
Girman et al.
Am J Epidemiol 2005;162:438-447.
ABSTRACT
| FULL TEXT
Tobacco Smoke Exposure Is Associated With the Metabolic Syndrome in Adolescents
Weitzman et al.
Circulation 2005;112:862-869.
ABSTRACT
| FULL TEXT
Dyslipidemia and Metabolic Syndrome in the Sisters of Women with Polycystic Ovary Syndrome
Sam et al.
J. Clin. Endocrinol. Metab. 2005;90:4797-4802.
ABSTRACT
| FULL TEXT
Fetal Programming and Risk of Metabolic Syndrome: Prevention Efforts for High-Risk Populations
Lobelo
Pediatrics 2005;116:519-519.
FULL TEXT
Cardiorespiratory Fitness Is Inversely Associated With the Incidence of Metabolic Syndrome: A Prospective Study of Men and Women
LaMonte et al.
Circulation 2005;112:505-512.
ABSTRACT
| FULL TEXT
Obesity, Insulin Resistance, and the Metabolic Syndrome: Determinants of Endothelial Dysfunction in Whites and Blacks
Lteif et al.
Circulation 2005;112:32-38.
ABSTRACT
| FULL TEXT
|
